Private Capital's ABT Position Overview
Private Capital (via Private Capital Management, LLC) currently holds 2,903 shares of Abbott Laboratories (ABT) worth $363,718, representing 0.03% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Private Capital has initiated a new position in ABT, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Private Capital's Abbott Laboratories (ABT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Abbott Laboratories (ABT) Trades by Private Capital
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +2,903 | New Buy | 2,903 | $125.29 |
Private Capital's Abbott Laboratories Investment FAQs
Private Capital first purchased Abbott Laboratories (ABT) in Q4 2025, acquiring 2,903 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Private Capital has held Abbott Laboratories (ABT) for 1 quarters since Q4 2025.
Private Capital's largest addition to Abbott Laboratories (ABT) was in Q4 2025, adding 2,903 shares worth $363,718.
According to the latest 13F filing for Q4 2025, Private Capital's firm, Private Capital Management, LLC, owns 2,903 shares of Abbott Laboratories (ABT), valued at approximately $363,718.
As of the Q4 2025 filing, Abbott Laboratories (ABT) represents approximately 0.03% of Private Capital's publicly disclosed stock portfolio, making it one of their key holdings.
Private Capital's peak holding in Abbott Laboratories (ABT) was 2,903 shares, as reported at the end of Q4 2025.